ProPhase Labs Current Ratio 2006-2019 | PRPH

ProPhase Labs current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
ProPhase Labs Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.01B $0.00B 12.32
2019-06-30 $0.01B $0.00B 14.05
2019-03-31 $0.01B $0.00B 16.24
2018-12-31 $0.02B $0.00B 4.31
2018-09-30 $0.02B $0.00B 20.66
2018-06-30 $0.02B $0.00B 12.26
2018-03-31 $0.03B $0.00B 16.89
2017-12-31 $0.03B $0.00B 15.68
2017-09-30 $0.03B $0.00B 10.60
2017-06-30 $0.04B $0.00B 10.00
2017-03-31 $0.05B $0.01B 6.51
2016-12-31 $0.01B $0.01B 1.41
2016-09-30 $0.01B $0.01B 1.56
2016-06-30 $0.01B $0.01B 1.64
2016-03-31 $0.01B $0.00B 2.36
2015-12-31 $0.01B $0.01B 2.62
2015-09-30 $0.01B $0.00B 2.92
2015-06-30 $0.01B $0.00B 2.57
2015-03-31 $0.01B $0.01B 2.25
2014-12-31 $0.01B $0.01B 2.57
2014-09-30 $0.02B $0.01B 2.15
2014-06-30 $0.01B $0.01B 2.30
2014-03-31 $0.01B $0.00B 2.62
2013-12-31 $0.01B $0.01B 2.44
2013-09-30 $0.01B $0.01B 2.23
2013-06-30 $0.01B $0.00B 2.01
2013-03-31 $0.01B $0.00B 2.65
2012-12-31 $0.01B $0.01B 2.18
2012-09-30 $0.01B $0.01B 1.58
2012-06-30 $0.01B $0.01B 1.43
2012-03-31 $0.01B $0.01B 1.65
2011-12-31 $0.01B $0.01B 1.68
2011-09-30 $0.01B $0.01B 1.90
2011-06-30 $0.01B $0.01B 2.04
2011-03-31 $0.01B $0.01B 1.91
2010-12-31 $0.02B $0.01B 1.91
2010-09-30 $0.02B $0.01B 2.08
2010-06-30 $0.01B $0.01B 2.16
2010-03-31 $0.02B $0.01B 2.45
2009-12-31 $0.02B $0.01B 2.58
2009-09-30 $0.02B $0.01B 2.61
2009-06-30 $0.01B $0.01B 2.47
2009-03-31 $0.02B $0.01B 2.97
2008-12-31 $0.02B $0.01B 3.13
2008-09-30 $0.02B $0.01B 3.31
2008-06-30 $0.02B $0.01B 3.18
2008-03-31 $0.03B $0.01B 3.45
2007-12-31 $0.03B $0.01B 2.81
2007-09-30 $0.03B $0.01B 2.83
2007-06-30 $0.02B $0.01B 2.69
2007-03-31 $0.03B $0.01B 3.25
2006-12-31 $0.03B $0.01B 3.22
2006-09-30 $0.03B $0.01B 3.56
2006-06-30 $0.02B $0.01B 4.02
2006-03-31 $0.03B $0.01B 3.33
2005-12-31 $0.03B $0.01B 3.16
2005-09-30 $0.03B $0.01B 3.49
2005-06-30 $0.02B $0.01B 3.98
2005-03-31 $0.02B $0.01B 3.85
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.021B $0.013B
ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE?, a zinc gluconate glycine product. COLD-EEZE? family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.471B 39.61
Takeda Pharmaceutical (TAK) Japan $60.597B 10.74
Astellas Pharma (ALPMY) Japan $32.582B 16.27
Eisai (ESALY) Japan $23.185B 44.70
Merck (MKGAF) Germany $17.215B 23.49
Grifols, S.A (GRFS) Spain $16.941B 22.20
Neurocrine Biosciences (NBIX) United States $9.626B 267.44
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $8.851B 36.42
Ionis Pharmaceuticals (IONS) United States $8.458B 17.13
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.968B 10.18
IPSEN SA ADR (IPSEY) France $6.104B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.461B 16.61
United Therapeutics (UTHR) United States $4.572B 0.00
Evotec AG (EVTCY) Germany $4.261B 68.88
Arrowhead Pharmaceuticals (ARWR) United States $4.195B 77.87
Nektar Therapeutics (NKTR) United States $4.069B 0.00
FibroGen (FGEN) United States $3.977B 116.87
PTC Therapeutics (PTCT) United States $3.559B 0.00
Sage Therapeutics (SAGE) United States $3.528B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.790B 11.29
ChemoCentryx (CCXI) United States $2.786B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.092B 0.00
Pacira Pharmaceuticals (PCRX) United States $2.086B 61.72
Xencor (XNCR) United States $2.070B 62.91
Ironwood Pharmaceuticals (IRWD) United States $1.891B 23.19
Heron Therapeutics (HRTX) United States $1.891B 0.00
Tilray (TLRY) Canada $1.748B 0.00
USANA Health Sciences (USNA) United States $1.626B 17.00
Corcept Therapeutics (CORT) United States $1.525B 18.53
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.469B 10.02
Zogenix (ZGNX) United States $1.424B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.424B 0.00
Endo (ENDP) Ireland $1.395B 2.56
Portola Pharmaceuticals (PTLA) United States $1.062B 0.00
Akebia Therapeutics (AKBA) United States $1.041B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.034B 32.03
Dermira (DERM) United States $1.022B 0.00
ImmunoGen (IMGN) United States $1.018B 0.00
Karyopharm Therapeutics (KPTI) United States $0.966B 0.00
Radius Health (RDUS) United States $0.922B 0.00
Aerie Pharmaceuticals (AERI) United States $0.901B 0.00
Collegium Pharmaceutical (COLL) United States $0.775B 0.00
TherapeuticsMD (TXMD) United States $0.673B 0.00
Flexion Therapeutics (FLXN) United States $0.631B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.543B 0.00
Molecular Templates (MTEM) United States $0.536B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.492B 59.63
BioSpecifics Technologies Corp (BSTC) United States $0.478B 20.59
Ardelyx (ARDX) United States $0.474B 0.00
Translate Bio (TBIO) United States $0.471B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.444B 0.00
Innate Pharma SA (IPHYF) France $0.442B 0.00
Organogenesis Holdings (ORGO) United States $0.431B 0.00
Recro Pharma (REPH) United States $0.420B 0.00
Indivior (INVVY) United States $0.417B 2.48
BioCryst Pharmaceuticals (BCRX) United States $0.415B 0.00
Siga Technologies (SIGA) United States $0.393B 8.98
DURECT (DRRX) United States $0.377B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.372B 0.00
Harpoon Therapeutics (HARP) United States $0.370B 0.00
Lannett Co Inc (LCI) United States $0.367B 5.91
Calithera Biosciences (CALA) United States $0.366B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.356B 0.00
Rafael Holdings (RFL) United States $0.349B 0.00
Concert Pharmaceuticals (CNCE) United States $0.322B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.320B 0.00
OptiNose (OPTN) United States $0.285B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.272B 0.00
KalVista Pharmaceuticals (KALV) United States $0.270B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.267B 0.00
Ocular Therapeutix (OCUL) United States $0.250B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.228B 0.00
MEI Pharma (MEIP) United States $0.227B 0.00
IMV INC (IMV) Canada $0.213B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.205B 0.00
Nature's Sunshine Products (NATR) United States $0.205B 35.27
Taiwan Liposome (TLC) Taiwan $0.200B 0.00
Jounce Therapeutics (JNCE) United States $0.194B 2.60
AcelRx Pharmaceuticals (ACRX) United States $0.127B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.125B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.124B 0.00
CannTrust Holdings (CTST) Canada $0.119B 0.00
Otonomy (OTIC) United States $0.114B 0.00
Aquestive Therapeutics (AQST) United States $0.110B 0.00
Redhill Biopharma (RDHL) Israel $0.110B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.108B 0.00
Xeris Pharmaceuticals (XERS) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.097B 0.00
CV Sciences (CVSI) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.084B 0.00
MediWound (MDWD) Israel $0.081B 0.00
Neos Therapeutics (NEOS) United States $0.078B 0.00
Infinity Pharmaceuticals (INFI) United States $0.078B 0.00
Onconova Therapeutics (ONTX) United States $0.074B 0.00
CTI BioPharma (CTIC) United States $0.072B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.070B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.068B 20.23
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
Aclaris Therapeutics (ACRS) United States $0.056B 0.00
Nivalis Therapeutics (ALPN) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.053B 0.00
VAXART, INC (VXRT) United States $0.052B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.052B 0.00
Natural Alternatives (NAII) United States $0.052B 23.44
Dipexium Pharmaceuticals (PLXP) United States $0.047B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.047B 0.00
PolarityTE (PTE) United States $0.046B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Mannatechorporated (MTEX) United States $0.038B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
Jaguar Animal Health (JAGX) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Biomerica (BMRA) United States $0.028B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.027B 0.00
China SXT Pharmaceuticals (SXTC) China $0.024B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Regulus Therapeutics (RGLS) United States $0.018B 0.00
Cardiome Pharma (CORV) Canada $0.017B 0.00
Shineco (TYHT) China $0.015B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.015B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Novan (NOVN) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Lipocine (LPCN) United States $0.012B 0.00
Vical (BBI) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00